Author: John F. Greden
Publisher: American Psychiatric Pub
ISBN: 1585624098
Category : Medical
Languages : en
Pages : 366
Book Description
This unique book presents the treatment "roadmap" implemented by the University of Michigan Comprehensive Depression Center's Treatment Resistant Depression Program, step-by-step guidance that has long eluded clinicians, patients, and their families. Writing across discipline, modality, lifespan, and patient demographics, the authors have compiled the most current thinking on TRD and distilled it into a highly readable, imminently practical, and brilliantly organized source of hope. The authors believe that early intervention is critical, and they advocate strategies for renewed focus on identifying youths who are at risk or already symptomatic. Similarly, they devote chapters to special populations such as pregnant women, older people, and those with comorbidities. Perhaps most useful to patients and their families, the book has a strong self-care orientation, emphasizing the importance of exercise, nutrition, and healthy sleep guidelines. Patients who are actively engaged in managing their disease often have better outcomes. Treatment Resistant Depression is frequently a lifetime diagnosis. The book acknowledges that fact and offers a systematic course of treatment grounded in evidence-based research that is current and comprehensive. Treatment Resistant Depression: A Roadmap for Effective Care offers a new way of conceptualizing an old enemy, and should prove to be an indispensable weapon in the battle.
Treatment Resistant Depression
Treatment-Resistant Mood Disorders
Author: Jay D. Amsterdam
Publisher: Cambridge University Press
ISBN: 9780521593410
Category : Medical
Languages : en
Pages : 566
Book Description
This timely book assesses all aspects of treatment-resistant depression and will be invaluable to professionals.
Publisher: Cambridge University Press
ISBN: 9780521593410
Category : Medical
Languages : en
Pages : 566
Book Description
This timely book assesses all aspects of treatment-resistant depression and will be invaluable to professionals.
Treatment-resistant Mood Disorders
Author: Andre Carvalho
Publisher: Oxford University Press, USA
ISBN: 0198707991
Category : Medical
Languages : en
Pages : 175
Book Description
Treatment-resistant major depression and bipolar disorder are highly prevalent and disabling conditions associated with substantial morbidity and mortality. Providing a concise view of the current definitions, assessment and evidence-based management of such disorders, this work reviews novel therapeutic targets, which may enhance the future therapeutic armamentarium of clinicians.
Publisher: Oxford University Press, USA
ISBN: 0198707991
Category : Medical
Languages : en
Pages : 175
Book Description
Treatment-resistant major depression and bipolar disorder are highly prevalent and disabling conditions associated with substantial morbidity and mortality. Providing a concise view of the current definitions, assessment and evidence-based management of such disorders, this work reviews novel therapeutic targets, which may enhance the future therapeutic armamentarium of clinicians.
Ketamine for Treatment-Resistant Depression
Author: Gustavo H. Vazquez
Publisher: Academic Press
ISBN: 0128210346
Category : Medical
Languages : en
Pages : 170
Book Description
Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. - Provides efficacy research on ketamine as a treatment for depression - Identifies best practices for clinical use, both long-term and acute - Discusses the molecular mechanisms and neurobiology of action
Publisher: Academic Press
ISBN: 0128210346
Category : Medical
Languages : en
Pages : 170
Book Description
Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. - Provides efficacy research on ketamine as a treatment for depression - Identifies best practices for clinical use, both long-term and acute - Discusses the molecular mechanisms and neurobiology of action
Ketamine for Treatment-Resistant Depression
Author: Sanjay J. Mathew
Publisher: Springer
ISBN: 3319429256
Category : Medical
Languages : en
Pages : 167
Book Description
This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic molecular targets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.
Publisher: Springer
ISBN: 3319429256
Category : Medical
Languages : en
Pages : 167
Book Description
This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic molecular targets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.
Managing Treatment-Resistant Depression
Author: Joao Luciano de Quevedo
Publisher: Elsevier
ISBN: 0128240679
Category : Medical
Languages : en
Pages : 612
Book Description
Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. Defines Treatment-Resistant Depression and Staging Treatment Intensity Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions Discusses the use of Ketamine and Esketamine for treatment-resistant depression
Publisher: Elsevier
ISBN: 0128240679
Category : Medical
Languages : en
Pages : 612
Book Description
Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. Defines Treatment-Resistant Depression and Staging Treatment Intensity Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions Discusses the use of Ketamine and Esketamine for treatment-resistant depression
Pharmacotherapy For Depression And Treatment-resistant Depression
Author: George I Papakostas
Publisher: World Scientific
ISBN: 9814466670
Category : Medical
Languages : en
Pages : 726
Book Description
This unique ground-breaking work, authored by renowned Harvard-based researchers G I Papakostas and M Fava, represents, by far, the most comprehensive compilation to date of medical studies and reports involving the use of antidepressants for the treatment of major depressive disorder, one of the most prevalent and devastating medical illnesses afflicting mankind today. Given the breadth of the scientific literature focusing on the use of antidepressants for major depressive disorder, this work represents an invaluable tool for clinicians as well as scientists in search of a reference manual to help guide them through the field. The book is organized into four parts; each part focusing on a separate theme that will facilitate the reader to precisely access particular information of interest, whether be it clinical or scientific in nature. Each part is then sub-divided into several thematic chapters, which are enriched with tables and figures citing results from the most influential studies in the field. Finally, clinical and research “pearls” are listed throughout the book in bullet-point fashion to help summarize the available knowledge-base in a user-friendly format.
Publisher: World Scientific
ISBN: 9814466670
Category : Medical
Languages : en
Pages : 726
Book Description
This unique ground-breaking work, authored by renowned Harvard-based researchers G I Papakostas and M Fava, represents, by far, the most comprehensive compilation to date of medical studies and reports involving the use of antidepressants for the treatment of major depressive disorder, one of the most prevalent and devastating medical illnesses afflicting mankind today. Given the breadth of the scientific literature focusing on the use of antidepressants for major depressive disorder, this work represents an invaluable tool for clinicians as well as scientists in search of a reference manual to help guide them through the field. The book is organized into four parts; each part focusing on a separate theme that will facilitate the reader to precisely access particular information of interest, whether be it clinical or scientific in nature. Each part is then sub-divided into several thematic chapters, which are enriched with tables and figures citing results from the most influential studies in the field. Finally, clinical and research “pearls” are listed throughout the book in bullet-point fashion to help summarize the available knowledge-base in a user-friendly format.
Recurrent Mood Disorders
Author: Gian F. Placidi
Publisher: Springer Science & Business Media
ISBN: 3642766463
Category : Medical
Languages : en
Pages : 314
Book Description
Current evidence indicates that over two-thirds of mood disorders pursue a recurrent or chronic course. Yet much of the progress recorded in the field of mood disorders and their treatment has been in research into the acute phase of the illness. Hence there is a need for a volume that specifically addresses the special clinical problems encountered inthe recurrent forms of these disorders. The various chapters of this book embrace a wide range of topics, including etiology, course, and long-term treatment, integrative reviews, results of recent investigations, and clinical reports. In this respect, the contributions reflect currentconcepts, research, and clinical practice. We have endeavored to build a bridge between neurobiology and psychology and have covered both the psychotherapeutic and the psychopharmacologic aspects of mood disorders.
Publisher: Springer Science & Business Media
ISBN: 3642766463
Category : Medical
Languages : en
Pages : 314
Book Description
Current evidence indicates that over two-thirds of mood disorders pursue a recurrent or chronic course. Yet much of the progress recorded in the field of mood disorders and their treatment has been in research into the acute phase of the illness. Hence there is a need for a volume that specifically addresses the special clinical problems encountered inthe recurrent forms of these disorders. The various chapters of this book embrace a wide range of topics, including etiology, course, and long-term treatment, integrative reviews, results of recent investigations, and clinical reports. In this respect, the contributions reflect currentconcepts, research, and clinical practice. We have endeavored to build a bridge between neurobiology and psychology and have covered both the psychotherapeutic and the psychopharmacologic aspects of mood disorders.
Management of Complex Treatment-resistant Psychotic Disorders
Author: Michael Cummings
Publisher: Cambridge University Press
ISBN: 1108965687
Category : Medical
Languages : en
Pages : 545
Book Description
An essential handbook providing practical guidance and medication advice on the effective management and treatment of psychotic disorders.
Publisher: Cambridge University Press
ISBN: 1108965687
Category : Medical
Languages : en
Pages : 545
Book Description
An essential handbook providing practical guidance and medication advice on the effective management and treatment of psychotic disorders.
Clinical Handbook for the Diagnosis and Treatment of Pediatric Mood Disorders
Author: Manpreet Kaur Singh, M.D., M.S.
Publisher: American Psychiatric Pub
ISBN: 1615371745
Category : Medical
Languages : en
Pages : 606
Book Description
This book is an authoritative and contemporary guide to the assessment and management of childhood-onset mood disorder.
Publisher: American Psychiatric Pub
ISBN: 1615371745
Category : Medical
Languages : en
Pages : 606
Book Description
This book is an authoritative and contemporary guide to the assessment and management of childhood-onset mood disorder.